Eli Chan
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism 21
- Fungal Biology and Applications 9
- Pharmacological Effects of Natural Compounds 5
- Antibiotics Pharmacokinetics and Efficacy 5
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 21
- Fungal Biology and Applications 9
- Pharmacological Effects of Natural Compounds 5
- Antibiotics Pharmacokinetics and Efficacy 5
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 15
- Cancer Treatment and Pharmacology 9
- Transplantation top 5%
-
- Pharmacological Effects and Toxicity Studies 11
-
- Cancer therapeutics and mechanisms 10
- Journals
- Current Drug Metabolism (11 papers)Pharmaceutical Research (8 papers)European Journal of Pharmaceutical Sciences (6 papers)
- Partner nations
- SingaporeChinaNew Zealand
In The Last Decade
Eli Chan
76 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 124
- Pharmacology 1.5k
- Complementary and alternative medicine 609
- Pharmacology 826
- Oncology 840
- Transplantation 75
Countries citing papers authored by Eli Chan
This map shows the geographic impact of Eli Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Chan more than expected).
Fields of papers citing papers by Eli Chan
This network shows the impact of papers produced by Eli Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Chan. The network helps show where Eli Chan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eli Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 5 | |
| 2 | 2011 | 21 | |
| 3 | 2011 | 14 | |
| 4 | 2009 | 63 | |
| 5 | 2007 | 20 | |
| 6 | 2007 | 29 | |
| 7 | 2006 | 10 | |
| 8 | 2006 | 35 | |
| 9 | 2006 | 48 | |
| 10 | 2006 | 45 | |
| 11 | 2006 | 24 | |
| 12 | 2005 | 87 | |
| 13 | 2005 | 64 | |
| 14 | 2005 | 48 | |
| 15 | 2005 | 15 | |
| 16 | 2005 | 391 | |
| 17 | 2005 | 26 | |
| 18 | 2005 | 27 | |
| 19 | 2004 | 39 | |
| 20 | 1993 | 73 |
About Eli Chan
Eli Chan is a scholar working on Pharmacology, Transplantation and Pharmacology, having authored 76 papers that have together received 3.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (21 papers), Drug Transport and Resistance Mechanisms (15 papers), Pharmacological Effects and Toxicity Studies (11 papers), Cancer therapeutics and mechanisms (10 papers), Cancer Treatment and Pharmacology (9 papers), Fungal Biology and Applications (9 papers), Pharmacological Effects of Natural Compounds (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). The work is most often cited by research in Pharmacology (1.5k citations), Complementary and alternative medicine (609 citations) and Pharmacology (826 citations). Eli Chan has collaborated with scholars based in Singapore, China and New Zealand. Frequent co-authors include Shu‐Feng Zhou, Wei Duan, Min Huang, Sui Yung Chan, Shufeng Zhou, Zeping Hu, Hwee‐Ling Koh, Yihuai Gao, Boon Cher Goh and Xiaotian Li. Their work appears in journals such as Current Drug Metabolism, Pharmaceutical Research, European Journal of Pharmaceutical Sciences, Journal of Chromatography B and Food Reviews International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.